| Literature DB >> 18426590 |
Stéphane Poitras1, Michel Rossignol, Clermont Dionne, Michel Tousignant, Manon Truchon, Bertrand Arsenault, Pierre Allard, Manon Coté, Alain Neveu.
Abstract
BACKGROUND: Low-back pain is responsible for significant disability and costs in industrialized countries. Only a minority of subjects suffering from low-back pain will develop persistent disability. However, this minority is responsible for the majority of costs and has the poorest health outcomes. The objective of the Clinic on Low-back pain in Interdisciplinary Practice (CLIP) project was to develop a primary care interdisciplinary practice model for the clinical management of low-back pain and the prevention of persistent disability.Entities:
Mesh:
Year: 2008 PMID: 18426590 PMCID: PMC2390556 DOI: 10.1186/1471-2474-9-54
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Three types of low-back pain to be used in patient triage
| General characteristics: |
| - Lumbar or lumbosacral pain with no neurological involvement |
| - "Mechanical" pain, varying over time and with physical activity |
| - Patient's general health is good |
| The patient should have one or more symptoms |
| |
| - Pain radiating below the knee, which is as intense or more intense than the back pain |
| - Pain often radiating to the foot or toes |
| - Numbness or paresthesia in the painful area |
| |
| - Positive sign for radicular irritation as tested, for example, by straight leg raising |
| - Motor, sensitivity or reflex signs supporting nerve root involvement. |
| General characteristics: |
| - Violent trauma (such as a fall from height or an automobile accident) |
| - Constant, progressive, non-mechanical pain |
| - Thoracic or abdominal pain |
| - Pain at night that is not eased by a prone position |
| - History of or suspected cancer, HIV or other pathologies that can cause back pain |
| - Chronic corticosteroid consumption |
| - Unexplained weight loss, chills or fever |
| - Significant and persistent limitation of lumbar flexion |
| - Loss of feeling in the perineum (saddle anesthesia), recent onset of urinary incontinence |
| The risk of a serious condition may be higher in those under 20 or over 55 years of age. Particular attention should be paid to the previously mentioned signs and symptoms in patients in these age groups. |
Therapeutic interventions for acute low-back pain (0–4 weeks)
| - Efficacy to ↓ pain = acetaminophen for all NSAIDs | - Efficacy > placebo [53] | - Efficacy > placebo or bed rest | |
| - Efficacy > mobilisation for short term pain reduction [55] | |||
| - Efficacy = conservative treatment [56,57] | |||
| -Efficacy of non-benzodiazepines > benzodiazepines; both with potential harm | - Efficacy of extension > flexion | - Non-opioids as efficacious as NSAIDs for pain relief | |
| - Opioids: weak evidence of superiority to non-opioids | |||
| - Efficacy > placebo | - Weak efficacy compared to no treatment | ||
| - Efficacy unknown compared to conventional therapies | |||
| - No efficacy for prevention | |||
| - Efficacy > conventional medical treatment | |||
| - Weak efficacy compared to other treatments | |||
| - No efficacy in meta-analysis | |||
NSAID: non-steroidal anti-inflammatory drugs
TENS: transcutaneous electrical nerve stimulation
Therapeutic interventions for subacute low-back pain (4–12 weeks)
| - Graded activity + behavioral intervention = ↓ absence from work and ↓ risk of chronicity | |||
| - no superiority of one type compared to another | - efficacious if intensive, includes return to work component with visit of workplace. | - Efficacy > placebo [53] | |
| - Efficacy > mobilisation to reduce short term pain [55] | |||
| - As efficacious as other conservative treatments | |||
| - Efficacy > no treatment | |||
| - Better efficacy if combined to exercises and education | |||
| - Efficacy on pain and functional limitations > traditional care | |||
| - Efficacy to ↓ pain = acetaminophen for all NSAIDs | |||
| - Non-opioids as efficacious as NSAIDs for pain relief | |||
| - Opioids: weak evidence of superiority to non-opioids | |||
NSAID: non-steroidal anti-inflammatory drugs
TENS: transcutaneous electrical nerve stimulation
Therapeutic interventions for persistent low-back pain (12 weeks +)
| - Efficacious if intensive, includes return to work component with visit of workplace. | - Efficacy if short term and on workplace premises | - Efficacy > no treatment | |
| - Better efficacy if combined to exercises and education | |||
| - Efficacy > no treatment or waiting list if includes cognitive approach and relaxation | - Efficacy to ↓ pain = acetaminophen for all NSAIDs | ||
| - No superiority of one type compared to another | |||
| - Better if individualised | |||
| - Evidence weaker than in acute phase | |||
| - Advantage over benzodiazepines | |||
| - Efficacy > placebo | |||
| - Advantage for tricyclic and tetracyclic | |||
| - Efficacy on pain and functional status | |||
| - Efficacy = other treatments | |||
NSAID: non-steroidal anti-inflammatory drugs
TENS: trans-cutaneous electrical nerve stimulation
Figure 1Clinical algorithm for acute low-back pain.
Figure 3Clinical algorithm for persistent low-back pain.
Figure 2Clinical algorithm for subacute low-back pain.